Home / Products / Inhibitors / EGFR inhibitor / 252916-29-3


Cat.No.ABP000880 Chemical NameSU-6668(TSU-68)/SU6668 MDL: MFCD09743433 MolFormulaC18H18N2O3 MolWeight310.351 Purity >98 %

Chemical Name : SU-6668(TSU-68)/SU6668

CAS : 252916-29-3

Synonyms: TSU-68

Solubility:Soluble in DMSO

Storage:at -20℃ 2 years


Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT. AMG 706 potently inhibited VEGF-induced but not bFGF-induced proliferation of HUVECs with IC50 values of 10 nmol/L and >3,000 nmol/L, respectively. Similarly, AMG 706 potently inhibited both PDGFinduced proliferation and SCF-induced c-kit phosphorylation with IC50 values of 207 and 37 nmol/L, respectively. AMG 706 displayed no activity against unrelated kinases as evidenced by the lack of activity against EGF-induced EGFR phosphorylation in A431 cells (IC50, >25 Amol/L).


1. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Polverino, A., Coxon, A., et al. 2006 Cancer Research 66 (17), pp. 8715-8721